News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
Stephan Winckels, MD, PhD, was promoted to chief medical officer (CMO) after joining the CRO three years ago as the head of the medical affairs department.
Winckels has more than ten years of experience in cancer research working at big pharma as well as CROs, including Wyeth (now Pfizer), Boehringer Ingelheim, and Julius Clinical.
“I am thrilled to continue my work in this new position at SMS-oncology,” Winckels told us. “With my expertise in clinical oncology trials and our bright, oncology focused team we are able to execute complex trials of innovative oncology products for our biotech clients.
“I look forward to leading our company in bringing safe and effective therapies to cancer patients and make a meaningful impact on their lives.”